What the Mount Raymond acquisition means for SLAM Exploration Ltd.’s Goodwin project scale (TSXV: SXL)
Read More 4 minute read Pharma Industry News FDA grants approval to Samsung Bioepis’ Ospomyv and Xbryk, expanding access to biosimilar treatments for osteoporosis and cancer-related bone loss The U.S. Food and Drug Administration (FDA) has approved Ospomyv™ and Xbryk™, two biosimilars developed by Samsung Bioepis… byPallavi MadhirajuFebruary 17, 2025